CEP-32496(RXDX-105)

99%

Reagent Code: #100001
fingerprint
CAS Number 1188910-76-0

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 517.46 g/mol
Formula C₂₄H₂₂F₃N₅O₅
badge Registry Numbers
MDL Number MFCD22124524
inventory_2 Storage & Handling
Storage -20℃

description Product Description

CEP-32496, also known as RXDX-105, is primarily investigated for its potential in cancer therapy. It functions as a selective inhibitor of RET (Rearranged during Transfection) kinase, which is often implicated in various cancers, including non-small cell lung cancer (NSCLC) and thyroid cancer. By targeting RET mutations and fusions, CEP-32496 aims to disrupt the signaling pathways that drive tumor growth and progression. Its application is particularly significant in patients with RET-altered tumors, where it offers a targeted treatment approach, potentially improving outcomes compared to traditional chemotherapy. Additionally, its role in combination therapies is being explored to enhance efficacy and overcome resistance mechanisms in advanced cancers.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 1mg
10-20 days ฿3,321.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB